ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption.

低カフェイン摂取の女性アスリートにおける様々なカフェイン用量の認知能力への影響 (機械翻訳の邦題)

Brain sciences2024Bougrine H, Ammar A, Salem A, et al.
研究デザインその他の原著論文
対象未確定

記録の確認項目

研究デザイン
その他の原著論文
対象
未確定
出版年
2024
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、低カフェイン摂取の女性アスリートを対象に、異なる用量のカフェイン摂取が認知能力に及ぼす影響を検討した無作為化クロスオーバー二重盲検試験である。14名の女性アスリート(平均年齢17.4歳)が、プラセボ、3 mg/kg、6 mg/kg、9 mg/kgのカフェインを摂取し、単純反応時間、選択反応時間、注意課題、心的回転課題を実施した。その結果、3 mg/kgと6 mg/kgのカフェインはプラセボと比較して単純反応時間、選択反応時間、注意課題の成績を有意に向上させたが、3 mg/kgと6 mg/kgの間に有意差はなかった。心的回転課題はどの用量でも改善しなかった。9 mg/kgでは認知能力の向上は見られず、副作用の発生率が最も高かった。結論として、低用量の3 mg/kgが認知能力向上に推奨される。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Caffeine (CAF), a prevalent psychoactive stimulant, is believed to potentially enhance cognitive ability. However, studies on the effects of various doses are limited and yield inconsistent results, particularly in female athletes. Therefore, we aimed to assess the association between three different dosages of CAF intake (low, moderate, and high) and cognitive skills in female athletes with low CAF consumption. This study had a randomized, crossover, double-blind design in which each athlete performed four experimental sessions after ingesting either a placebo (PLAC), 3 mg·kg-1 of CAF (3 mg of CAF), 6 mg·kg-1 of CAF (6 mg of CAF), or 9 mg·kg-1 of CAF (9 mg of CAF) with an in-between washout period of at least 72 h. Following a 60 min window post-capsule consumption, fourteen female athletes (age: 17.4 ± 0.8 years) were assessed through various cognitive tests, namely, simple reaction time (SRT), choice reaction time (CRT), and attentional task (AT) tests, along with the mental rotation test (MRT). Additionally, they were required to complete a questionnaire about the undesirable side effects of CAF. Our results indicated that, compared to those of PLAC, the SRT, CRT, and AT performance were significantly improved following the administration of both 3 mg of CAF and 6 mg of CAF. While the greatest enhancement was observed after consuming 3 mg of CAF, no significant differences were found between the effects of 3 mg and 6 mg of CAF. Interestingly, MRT performance did not improve with any of the CAF dosages. Moreover, the ingestion of 9 mg of CAF did not enhance cognitive skills and was linked to the highest occurrence of CAF-related side effects. In conclusion, our results highlight the recommendation for a low CAF dosage of 3 mg·kg-1, in contrast to a higher dose of 6 mg·kg-1 or 9 mg·kg-1 of CAF, to enhance various aspects of cognitive performance in female athletes with low CAF consumption without adverse side effects.

DOI 10.3390/brainsci14030280

PMID 38539668

原文・出典を見る →